Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

BACKGROUND: Plasma‐derived tumour‐specific cell‐free nucleic acids are increasingly utilized as a minimally invasive, real‐time biomarker approach in many solid tumours. Circulating tumour DNA of melanoma‐specific mutations is currently the best studied liquid biopsy biomarker for melanoma. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Lea Jessica, Höwner, Anna, Griewank, Klaus, Lueong, Smiths S., von Neuhoff, Nils, Horn, Peter A., Sucker, Antje, Paschen, Annette, Livingstone, Elisabeth, Ugurel, Selma, Zimmer, Lisa, Horn, Susanne, Siveke, Jens T., Schadendorf, Dirk, Váraljai, Renáta, Roesch, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626658/
https://www.ncbi.nlm.nih.gov/pubmed/36320118
http://dx.doi.org/10.1002/ctm2.1090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626658/
https://www.ncbi.nlm.nih.gov/pubmed/36320118
http://dx.doi.org/10.1002/ctm2.1090

Ejemplares similares